glp 1 agonist microdosing GLP-1 Drugs: What To Know Can Microdosing GLP 1 Enhance
Description
Some studies propose potentially cardioprotective and renoprotective actions, while others highlight an enhanced vulnerability of some DPP-4 inhibitors to cause heart failure

Torley D, Bellus GA, Munro CS

Diabetes Obes Metab 2017;19:123341.PubMed 83
Who its best for: Those who must keep costs low

[71] have also demonstrated that treatment with exenatide, as well as pioglitazone, improves liver injury rates in patients with T2DM

As we look ahead to the remainder of 2025 and into 2026, we have several efforts underway to address the increase in medical and pharmacy costs across Independence Health Group, including our work to transition from high-cost drugs, like Humira, to biosimilars, Lopez said
